Merck & Co., Inc.

Merck & Co., Inc.

Sector: Pharmaceutical Preparations Region: NJ, United States

: | XETRA: 6MK | New York Stock Exchange: MRK | Euronext Paris: MRK | Mexican Stock Exchange: MRK

Similar to: Skystar Bio-Pharmaceutical Co., Sareum Holdings Plc, United-Guardian, Inc.

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company's products cover a broad range of areas, including heart and respiratory health, infectious diseases, sun care and women's health. It provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company operates its business through four operating segments: Pharmaceutical, Animal Health, Consumer Care and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The company sells these products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Its vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The company sells these vaccines primarily to physicians, wholesalers, physician distributors and government entities. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines, which it sells to veterinarians, distributors and animal producers. The Consumer Care segment develops, manufactures and markets over-the-counter, foot care and sun care products, which are sold through wholesale and retail drug, food chain and mass merchandiser outlets in the United States and Canada. The Alliances segment includes revenue from the company relationship with AstraZeneca LP. The company was founded in 1851 and is headquartered in Whitehouse Station, NJ.

Investor Calendar

Latest Media

Warning! Third-party cookies must be enabled to view SlideShare presentations. ×

Having trouble?

Corporate Responsibility

No description available.

Merck & Co., Inc. video

Corporate Responsibility

Merck & Co., Inc. video

Question to Merck CEO Regarding Merck's Continuing Support for ObamaCare

Merck & Co., Inc. video

Merck - Company Overview


Kenneth C. Frazier, Chairman, President and Chief Executive Officer
Kenneth C. Frazier is chairman of the board, president and chief executive officer of Merck & Co., Inc. Previously, Ken served as president of Merck, with responsibility for the company’s three major divisions: Global Human Health, Merck’s sales and marketing division for pharmaceutical and vaccine products; Merck Manufacturing Division, Merck’s manufacturing and supply division; and Merck Research Laboratories, Merck’s research organization. Ken has held a broad range of senior management positions since joining Merck in 1992 as vice president, general counsel and secretary of the Astra Merck Group. He was elected vice president of public affairs in 1994 and in 1997 assumed the additional responsibilities of assistant general counsel, corporate staff. Ken was promoted to vice president and deputy general counsel in January 1999. In December 1999, he became senior vice president and general counsel. In this role, he oversaw Merck’s legal and public affairs functions and The Merck Company Foundation. In November 2006, he was promoted to executive vice president and general counsel. Ken served as executive vice president and president, Global Human Health, from 2007 to May 2010, when he became Merck president. Ken became CEO and member of the board of directors January 1, 2011, and became chairman of the board on December 1, 2011. Before joining Merck, Ken was a partner with the Philadelphia law firm of Drinker Biddle & Reath. Ken sits on the boards of PhRMA, Weill Cornell Medical College and Graduate School of Medical Sciences, Exxon Mobil Corporation, The Pennsylvania State University and Cornerstone Christian Academy in Philadelphia, PA. Ken also is a member of the American Academy of Arts and Sciences, the Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association. Ken received his bachelor’s degree from The Pennsylvania State University and holds a J.D. from Harvard Law School.
Willie A. Deese, Executive Vice President and President, Merck Manufacturing Divi
Executive vice president and president, Merck Manufacturing Division, 2008 President, Merck Manufacturing Division, 2005-2007 Senior vice president, Global Procurement, Merck & Co., Inc., 2004-2005
Peter N. Kellogg, Chief Financial Officer
Executive vice president and chief financial officer, Merck & Co., Inc., 2007 Executive vice president and chief financial officer, Biogen Idec Inc., 2004-2007 Executive vice president and chief financial officer, Biogen Inc., 2000-2003 Senior vice president, PepsiCo E-Commerce, 2000 Senior vice president and chief financial officer, Frito Lay International, 1998-2000

News & Analysis

You may also be interested in: